Platform Technology Partners Corbus Pharmaceuticals Holdings, Inc. Transaction History

Platform Technology Partners

  • $312 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022
SELL
$0.32 - $0.67 $3,600 - $7,537
-11,250 Reduced 25.0%
33,750 $18,000
Q4 2021

Feb 01, 2022
SELL
$0.6 - $1.11 $9,000 - $16,650
-15,000 Reduced 25.0%
45,000 $28,000
Q3 2020

Nov 30, 2020
BUY
$1.5 - $9.38 $60,000 - $375,200
40,000 Added 200.0%
60,000 $108,000
Q1 2020

Nov 30, 2020
BUY
$3.44 - $7.21 $68,800 - $144,200
20,000 New
20,000 $105,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.22B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email